英国标准协会BSI：2026年七国集团净零温度检查：制药行业见解报告（英文版）

G7 countries, and the businesses in them, are at various stages of their net zero journeys. Amidst geopolitical instability, rising energy costs and political change, questions have been raised about the cost of net zero, the commitment of businesses to sustainability and how they can turn ambition into action. Over the past decade, the awareness of sustainability risks to public health has grown 1 , shifting the conversation within the pharmaceutical sector from a focus on reducing operational